Advanced gastric cancer in an elderly woman showing histopathologic CR after a course of S-1 and CDDP combination therapy

Japanese Journal of Cancer and Chemotherapy

Volumn 37, Issue 4, 2010, Pages 711-713

  Kadokawa, Yoshio ^a   Sonoda, Kentaro ^a   Nakajima, Sanae ^a   Kawabe, Atsushi ^a   Egawa, Hiroto ^a  

^a Murakami Memorial Hospital   (Japan)

Author keywords

Gastric cancer; Pathological complete response

Indexed keywords

CISPLATIN; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR;

ADVANCED CANCER; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CASE REPORT; FEMALE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; STOMACH CANCER; TREATMENT RESPONSE;

EID: 79960798402     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Koizumi W, Narahara H, Hara T, et al: S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial) : a phase III trial. Lancet Oncol 9(3):215-221, 2008.
2. Chun HG, Puccio CA, Mittelman A, et al: Weekly docetaxel and continuous infusion (CI) 5-fluorouracil (5-FU) in elderly patients (Pts) with cancer of the stomach and distal esophagus. Proc ASCO 20:162a, 2001.